Imricor Medical Systems Inc (ASX:IMR)
A$ 0.49 -0.03 (-5.77%) Market Cap: 123.67 Mil Enterprise Value: 137.83 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 18/100

Q4 2022 Imricor Medical Systems Inc Cashflow Reports Call Transcript

Jan 26, 2022 / 10:00PM GMT
Release Date Price: A$0.968436
Aisha Jabeen

Good morning, everyone, and welcome to Imricor's quarterly results for the period ending 31 December 2021. My name is Aisha Jabeen, and I will be moderating this morning's call. I am pleased to be joined by Steve Wedan, Imricor's CEO; and Lori Milbrandt, Imricor's CFO. Steve will provide an update on Imricor's activities during the quarter, followed by a question-and-answer session. I'll give instructions on how to ask a question at the end of the briefing. With that, I'll hand over to Steve.

Steve Wedan
Imricor Medical Systems, Inc. - CEO, President & Executive Chairman

Thanks, Aisha. I just want to check. Can you hear me?

Aisha Jabeen

Yes.

Steve Wedan
Imricor Medical Systems, Inc. - CEO, President & Executive Chairman

Okay. Thank you, everyone, for joining us today, and Happy New Year. As Aisha said, I'll make some comments on the quarterly update we released this morning. But for those of you joining us today who are new to the Imricor's story, let me start

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot